Recent Updates
Recently added Catalysts

Heatwrap 1

Phase 3

Healthy | Unknown | Other |Pfizer, Inc.|Last Updated: Jun 19, 2012

Success Probability
Approval Probability 71%
TA Base Rate26%
Adjusted LOA41%
ML RiskLOW_RISK
Premium
Market & Valuation
rNPV $3.2B
Market Size $9.4B
Revenue Basis $1.6B
Competitors 6
Premium
Trial Design
UNCONTROLLEDBiomarker
Total Trials1
Total Enrollment169
FDA Designations
No designations recorded
Clinical Trials (1)
NCT IDTitlePhaseStatusEnrollmentVelocityDesignStartCompletionLast UpdatedSitesCountries
NCT01055262Safety, Tolerability And On-Body Temperature Of A Disposable Heatwrap Device For The Lower BackPHASE3 COMPLETED 169Jan 1, 2010Feb 1, 2010Jun 19, 2012 -
Unlock Drug Trial Details
Study Endpoints
Primary Endpoints
Percentage of Participants With a Significant Skin Event (Day 5 Cumulative)
Day 2 to Day 6

Events associated with Day X wear (eg, Day 5) assessed morning of Day X+1 (eg, Day 6). Significant skin event: at least moderate erythema, elevated response or pain upon touch (associated with non-zero erythema). Erythema grading scale: 0 (no visible erythema) to 3.0 (severe erythema, very intense redness) with 0.5 increments. Moderate erythema (2.0): definite redness. Elevated response: edema, papules, vesicle (≤ 0.5 centimeter \[cm\] diameter), bullae (\> 0.5 cm diameter), miliaria rubra, profunda or follicular response. Pain upon touch: skin grader asked "Does your skin hurt when I touch it?"

Secondary Endpoints
Percentage of Participants With Significant Skin Event (Days 1 Through 4 Cumulative)
Day 2 to Day 5
Time to First Significant Skin Event
Baseline to Day 6
Percentage of Participants With Any Non-zero Erythema Score or Elevated Response (Days 1 Through 5 Cumulative)
Day 2 to Day 6
Unlock Study Endpoints
Study Design & Arms
AllocationNON_RANDOMIZED
MaskingNONE
ModelSINGLE_GROUP
Treatment Arms
ArmTypeDescription
Heatwrap 1EXPERIMENTALExperimental heatwrap device for the lower back
Interventions
NameTypeDescription
Heatwrap 1DEVICE8 hours continuous topically-applied heat
Unlock Study Design Details
Eligibility Criteria
Age Range35 Years — N/A
SexALL
Healthy VolunteersYes

Inclusion Criteria: * The subject is a male or female in generally good health greater or equal to 35 years of age; * Female subjects of child-bearing potential and those who are post-menopausal for less than 2 years must be using a medically-approved method of contraception (i.e., oral, transderma...

Unlock Eligibility Criteria